XML 30 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2020   59,000      
Beginning balance at Dec. 31, 2020 $ 2,096 $ 0 $ 199 $ 37 $ 1,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 228       228
Common stock purchases (in shares)   (1,000)      
Common stock purchases (122)   (2)   (120)
Other comprehensive loss, net (11)     (11)  
Share-based compensation (27)   (27)    
Ending balance (in shares) at Mar. 31, 2021   58,000      
Ending balance at Mar. 31, 2021 2,164 $ 0 170 26 1,968
Beginning balance (in shares) at Dec. 31, 2020   59,000      
Beginning balance at Dec. 31, 2020 2,096 $ 0 199 37 1,860
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 556        
Other comprehensive loss, net (20)        
Ending balance (in shares) at Sep. 30, 2021   58,000      
Ending balance at Sep. 30, 2021 2,518 $ 0 205 17 2,296
Beginning balance (in shares) at Mar. 31, 2021   58,000      
Beginning balance at Mar. 31, 2021 2,164 $ 0 170 26 1,968
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 185       185
Share-based compensation 21   21    
Ending balance (in shares) at Jun. 30, 2021   58,000      
Ending balance at Jun. 30, 2021 2,370 $ 0 191 26 2,153
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 143       143
Other comprehensive loss, net (9)     (9)  
Share-based compensation 14   14    
Ending balance (in shares) at Sep. 30, 2021   58,000      
Ending balance at Sep. 30, 2021 2,518 $ 0 205 17 2,296
Beginning balance (in shares) at Dec. 31, 2021   58,000      
Beginning balance at Dec. 31, 2021 2,630 $ 0 236 (5) 2,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 258       258
Other comprehensive loss, net (76)     (76)  
Share-based compensation (in shares)   1,000      
Share-based compensation (18)   (18)    
Ending balance (in shares) at Mar. 31, 2022   59,000      
Ending balance at Mar. 31, 2022 2,794 $ 0 218 (81) 2,657
Beginning balance (in shares) at Dec. 31, 2021   58,000      
Beginning balance at Dec. 31, 2021 2,630 $ 0 236 (5) 2,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 736        
Other comprehensive loss, net (180)        
Ending balance (in shares) at Sep. 30, 2022   58,000      
Ending balance at Sep. 30, 2022 3,041 $ 0 289 (185) 2,937
Beginning balance (in shares) at Mar. 31, 2022   59,000      
Beginning balance at Mar. 31, 2022 2,794 $ 0 218 (81) 2,657
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 248       248
Common stock purchases (in shares)   (658)      
Common stock purchases (200)   (2)   (198)
Other comprehensive loss, net (47)     (47)  
Share-based compensation 35   35    
Ending balance (in shares) at Jun. 30, 2022   58,000      
Ending balance at Jun. 30, 2022 2,830 $ 0 251 (128) 2,707
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 230       230
Other comprehensive loss, net (57)     (57)  
Share-based compensation (in shares)   0      
Share-based compensation 38   38    
Ending balance (in shares) at Sep. 30, 2022   58,000      
Ending balance at Sep. 30, 2022 $ 3,041 $ 0 $ 289 $ (185) $ 2,937